
Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …

Japanese drug firm Takeda (TYO: 4502) and Israel-based Teva (NYSE: TEVA) named Hiroshi Matsumori the chief executive for their newly-formed …

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

GlaxoSmithKline and telecoms giant Qualcomm are reportedly discussing a joint venture agreement worth as much as $1 billion, as the …
Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …

